VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CCCC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CCCCC4 Therapeutics, Inc.
$4.35$360M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCCCCQuarterly Financials

C4 Therapeutics, Inc. (CCCC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

C4 Therapeutics, Inc. (CCCC) quarterly income statement — complete revenue, gross profit & net income history

CCCC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue6.15M11.02M11.23M6.46M7.24M5.18M15.36M12.01M3.04M3.26M11.07M2.66M3.76M2.85M6.75M13.83M7.65M20.08M8.5M9.78M
Revenue Growth %-15%112.79%-26.9%-46.17%138.17%58.76%38.75%350.68%-19.15%14.26%63.93%-80.74%-50.89%-85.79%-20.54%41.44%3.07%143.02%0.63%1.15%
Cost of Goods Sold1.8M00001.77M2.06M2.04M01.69M2M029.04M30.65M29.66M31.32M26.2M26.55M24.3M23.29M
COGS % of Revenue29.28%----34.11%13.38%17.03%-51.86%18.02%-772.6%1074%439.19%226.42%342.34%132.24%285.91%238.07%
Gross Profit4.35M11.02M11.23M6.46M7.24M3.41M13.31M9.96M3.04M1.57M9.08M2.66M-25.28M-27.8M-22.91M-17.49M-18.55M-6.47M-15.8M-13.51M
Gross Margin %70.73%100%100%100%100%65.89%86.62%82.97%100%48.14%81.98%100%-672.6%-974%-339.19%-126.42%-242.34%-32.24%-185.91%-138.07%
Gross Profit Growth %-39.89%222.96%-15.6%-35.12%138.17%117.26%46.59%273.91%112.02%105.65%139.62%115.23%-36.3%-329.45%-44.98%-29.5%-41.6%46.82%-287.07%-239.66%
Operating Expenses32.14M34.16M45.64M34.96M36.4M41.12M41.55M31.4M35.26M39M36.88M40.23M10.95M10.49M9.58M9.89M12.82M8.78M8.45M8.61M
OpEx % of Revenue522.37%310.1%406.43%540.99%502.93%794.28%270.47%261.56%1160.18%1195.86%333.14%1510.21%291.17%367.73%141.83%71.53%167.49%43.74%99.44%88.04%
Selling, General & Admin7.53M9.18M8.92M8.77M9.33M10.37M11.77M9.7M10.29M8.61M10.53M10.31M10.95M10.49M9.58M9.89M12.82M8.78M8.45M8.61M
SG&A % of Revenue122.4%83.32%79.43%135.65%128.9%200.37%76.6%80.75%338.53%263.91%95.13%386.86%291.17%367.73%141.83%71.53%167.49%43.74%99.44%88.04%
Research & Development24.61M24.98M25.99M26.2M27.07M32.51M31.84M23.75M22.53M30.39M28.35M29.93M29.04M30.65M29.66M31.32M26.2M26.55M24.3M23.29M
R&D % of Revenue399.97%226.78%231.42%405.34%374.03%628.03%207.25%197.84%741.46%931.95%256.02%1123.35%772.6%1074%439.19%226.42%342.34%132.24%285.91%238.07%
Other Operating Expenses001000K00-1000K-1000K-1000K1000K0-1000K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-27.79M-23.14M-34.41M-28.5M-29.16M-37.71M-28.24M-21.44M-32.22M-37.43M-27.81M-37.57M-36.23M-38.29M-32.49M-27.38M-31.37M-15.26M-24.25M-22.12M
Operating Margin %-451.64%-210.1%-306.43%-440.99%-402.93%-728.39%-183.86%-178.59%-1060.18%-1147.72%-251.16%-1410.21%-963.77%-1341.73%-481.02%-197.95%-409.84%-75.98%-285.34%-226.11%
Operating Income Growth %4.73%38.62%-21.84%-32.92%9.48%-0.75%-1.57%42.92%11.07%2.26%14.41%-37.19%-15.49%-151.02%-33.95%-23.82%23.56%19.3%-32.18%-103.67%
EBITDA-25.98M-22.72M-33.95M-27.89M-28.71M-35.94M-26.19M-19.4M-31.77M-35.74M-25.81M-37.11M-35.68M-37.77M-32.07M-26.95M-31.06M-14.93M-23.92M-21.73M
EBITDA Margin %-422.37%-206.22%-302.33%-431.47%-396.63%-694.28%-170.47%-161.56%-1045.44%-1095.86%-233.14%-1393.02%-949.27%-1323.48%-474.87%-194.8%-405.85%-74.37%-281.46%-222.14%
EBITDA Growth %9.49%36.8%-29.65%-43.76%9.64%-0.58%-1.45%47.73%10.96%5.39%19.52%-37.7%-14.87%-152.96%-34.06%-24.03%23.46%19.45%-33.44%-108.06%
D&A (Non-Cash Add-back)1.8M428K460K615K456K1.77M2.06M2.04M448K1.69M2M458K545K521K415K435K305K323K330K388K
EBIT-27.79M-23.14M-32.17M-28.5M-29.16M-34.44M-24.67M-17.72M-29.78M-34.48M-25.87M-35.32M-36.23M-38.29M-32.49M-27.38M-31.37M-15.26M-24.25M-22.12M
Net Interest Income02.78M2.25M2.48M2.84M3.27M3.58M3.73M3.86M2.95M2.4M1.65M1.45M1.11M530K-28K-251K-403K-429K-464K
Interest Income02.78M2.25M2.48M2.84M3.27M3.58M3.73M3.86M2.95M2.56M2.25M2.05M1.71M1.08M506K276K136K110K69K
Interest Expense0000000000167K600K606K601K554K534K527K539K539K533K
Other Income/Expense2.66M2.78M2.25M2.48M2.84M3.27M3.58M3.73M3.86M2.95M1.77M1.65M1.45M1.11M530K-28K-251K-403K-429K-464K
Pretax Income-25.13M-20.36M-32.17M-26.02M-26.32M-34.44M-24.67M-17.72M-28.36M-34.48M-26.03M-35.92M-34.78M-37.19M-31.96M-27.41M-31.62M-15.66M-24.68M-22.58M
Pretax Margin %-408.47%-184.87%-286.43%-402.6%-363.66%-665.29%-160.56%-147.56%-933.23%-1057.25%-235.13%-1348.42%-925.25%-1302.91%-473.17%-198.15%-413.12%-77.99%-290.39%-230.86%
Income Tax0121K000131K000277K1M000000000
Effective Tax Rate %0%-0.59%0%0%0%-0.38%0%0%0%-0.8%-3.85%0%0%0%0%0%0%0%0%0%
Net Income-25.13M-20.49M-32.17M-26.02M-26.32M-34.57M-24.67M-17.72M-28.36M-34.75M-27.04M-35.92M-34.78M-37.19M-31.96M-27.41M-31.62M-15.66M-24.68M-22.58M
Net Margin %-408.47%-185.97%-286.43%-402.6%-363.66%-667.82%-160.56%-147.56%-933.23%-1065.75%-244.19%-1348.42%-925.25%-1302.91%-473.17%-198.15%-413.12%-77.99%-290.39%-230.86%
Net Income Growth %4.53%40.75%-30.41%-46.87%7.19%0.52%8.77%50.68%18.46%6.54%15.4%-31.04%-9.99%-137.48%-29.47%-21.4%-50.78%28.16%-13.04%-109.21%
Net Income (Continuing)-25.13M-20.49M-32.17M-26.02M-26.32M-34.57M-24.67M-17.72M-28.36M-34.75M-27.04M-35.92M-34.78M-37.19M-31.96M-27.41M-31.62M-15.66M-24.68M-22.58M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.20-0.18-0.44-0.37-0.37-0.49-0.35-0.26-0.41-0.68-0.55-0.73-0.69-0.74-0.64-0.56-0.65-0.32-0.51-0.51
EPS Growth %45.95%63.27%-25.71%-42.31%9.76%27.94%36.36%64.38%40.58%8.11%14.06%-30.36%-6.15%-131.25%-25.49%-9.8%-32.65%39.62%5.56%-96.15%
EPS (Basic)-0.20-0.18-0.44-0.37-0.37-0.49-0.35-0.26-0.41-0.68-0.55-0.73-0.69-0.74-0.64-0.56-0.66-0.32-0.51-0.51
Diluted Shares Outstanding126.07M116.78M72.56M71.01M70.83M70.61M69.63M68.81M68.43M51.22M49.21M49.06M49.03M48.97M48.92M48.82M48.73M48.49M48.49M43.86M
Basic Shares Outstanding126.07M116.78M72.56M71.01M70.83M70.61M69.63M68.81M68.43M51.22M49.21M49.06M49.03M48.97M48.92M48.82M48.65M48.49M48.49M43.86M
Dividend Payout Ratio--------------------